Background and Purpose-Cerebral arteriolar dilation to N-methyl-D-aspartate (NMDA) is a neuronally mediated multistep process that is sensitive to cerebral hypoxia and ischemia (H/I). We tested the hypothesis that topical pretreatment with the selective potassium channel agonists NS1619 and aprikalim preserves the vascular response to NMDA after consecutive H/I. Methods-Pial arteriolar diameters were measured in anesthetized piglets with the use of a closed cranial window and intravital microscopy. Arteriolar responses to NMDA (10 Ϫ5 , 5ϫ10 Ϫ5 , and 10 Ϫ4 mol/L) were recorded before and 1 hour after 10 minutes of hypoxia (8.5% O 2 in N 2 ) plus 10 minutes of ischemia (H/I). Ischemia was induced by increasing intracranial pressure. Subgroups were topically pretreated with 10 Ϫ5 mol/L NS1619, 10 Ϫ6 mol/L aprikalim, 10 Ϫ6 mol/L calcitonin gene-related peptide (CGRP), or 10 Ϫ5 mol/L papaverine. We also examined the effects of H/I on vascular responses to kainate (10 Ϫ4 mol/L) to assess specificity of neuronal injury. Results-Arteriolar responses to NMDA were significantly attenuated after H/I. Baseline compared with post-H/I arteriolar diameters were 9Ϯ4% versus 3Ϯ2% at 10 Ϫ5 mol/L, 22Ϯ4% versus 4Ϯ2% at 5ϫ10 Ϫ5 mol/L, and 33Ϯ4% versus 7Ϯ2% at 10 Ϫ4 mol/L (meanϮSE; all PϽ.05, nϭ7). Pretreatment with NS1619 and aprikalim preserved the arteriolar responses to NMDA after H/I. For NS1619 (nϭ6), values were as follows: 9Ϯ2% versus 6Ϯ4% at 10 Ϫ5 mol/L, 19Ϯ6% versus 21Ϯ5% at 5ϫ10 Ϫ5 mol/L, and 35Ϯ3% versus 31Ϯ5% at 10 Ϫ4 mol/L. For aprikalim (nϭ7), values were as follows: 6Ϯ2% versus 8Ϯ2% at 10 Ϫ5 mol/L, 22Ϯ6% versus 15Ϯ3% at 5ϫ10 Ϫ5 mol/L, and 41Ϯ5% versus 32Ϯ6% at 10